|
| |
Optic AtrophyDownload PDF containing detailed information.
Recent Publications on Optic Atrophy: |  |
[Treatment of optic neuropathies--state of the art]
Optic nerve diseases have various causes and are together with macular... | 17th November, 2009
| Universitats-Augenklinik Freiburg, Killianstrasse 5, Freiburg.
| Klin Monbl Augenheilkd. 2009 Nov;226(11):875-80. Epub 2009 Nov 13.
DOI Direct Link |
Genetically determined optic neuropathies.
PURPOSE OF REVIEW: The present review focuses on recent advances in the... | 17th November, 2009
| aDepartment of Ophthalmology, Angers University Hospital, Angers, France
| Curr Opin Neurol. 2009 Nov 12.
DOI Direct Link |
Ethambutol-Induced Optic Neuropathy Linked to OPA1 Mutation and Mitochondrial Toxicity.
Ethambutol (EMB), widely used in the treatment of tuberculosis, has been... | 11th November, 2009
| INSERM, U694, Angers, F-49000 France; Universite d'Angers, Faculte de
| Mitochondrion. 2009 Nov 6.
DOI Direct Link |
[Retinopathy in severe acute pancreatitis]
Retina examination performed in patients with severe acute pancreatitis... | 11th November, 2009
| Clinica Anestezie si Terapie Intensiva, UMF Craiova.
| Oftalmologia. 2009;53(3):123-9.
|
Phenotypic Spectrum of MFN2 Mutations in the Spanish Population.
The most common form of axonal Charcot-Marie-Tooth disease (CMT) is type... | 6th November, 2009
| 1 Unitat de Neuromuscular. Hospital Universitari de Bellvitge - IDIBELL,
| J Med Genet. 2009 Nov 3.
DOI Direct Link |
→View more research publications. |
Press Releases About Optic Atrophy:
|
 |
| Radiall and Integral Process Sign Agreement |
19th November, 2009 |
Radiall |
PARIS, Nov. 19 /PRNewswire/ -- Radiall and Integral Process will collaborate in developing and marketing new products for medical applications, signing an agreement to confirm this new alliance.
|
| Repligen Reports Second Quarter Fiscal Year 2010 Financial Results |
5th November, 2009 |
Repligen Corporation |
WALTHAM, Mass., Nov. 5 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) today reported results for the second quarter of fiscal year 2010, ended September 30, 2009. Total revenue for the
|
| Families of Spinal Muscular Atrophy Licenses Potential Treatment for SMA to Repligen Corporation |
22nd October, 2009 |
Families of Spinal Muscular Atrophy |
ELK GROVE VILLAGE, Ill., Oct. 22 /PRNewswire-USNewswire/ -- Families of Spinal Muscular Atrophy (FSMA) announced today that it has entered into a groundbreaking exclusive license agreement with
|
| Repligen Licenses Potential Treatment for Spinal Muscular Atrophy |
22nd October, 2009 |
Repligen Corporation |
WALTHAM, Mass., Oct. 22 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) announced today that it has entered into an exclusive license agreement with Families of Spinal Muscular Atrophy
|
| United States Patent and Trademark Office Publishes Stemedica's Patent Application for the Treatment of Diabetic Retinopathy |
8th September, 2009 |
Stemedica Cell Technologies, Inc. |
SAN DIEGO, Sept. 8 /PRNewswire/ -- http://www.stemedica.com/ Stemedica Cell Technologies, Inc., ("Stemedica"), a world leader in stem cell research and manufacturing, has filed a patent application
|
BioPortfolio Ltd. offers e-mail and postal lists for Optic Atrophy scientists - we have details of around 459 individuals working on Optic Atrophy .
This page has been viewed 584 times
Recent Search Terms used to find this page: research into cure for optic atrophy | stem cell treatment optic atrophy | stem cell treatment optic atrophy | stem cells optic nerve atrophy 2009 | optic atrophy diabetic medication | cures for optic nerve atrophy in us 2009 | trials in dominant optic atrophy | Stem cell optic atrophy ADOA 2009 | optic atrophy drug trial | .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Optic Atrophy across BioPortfolio, or for Optic Atrophy Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
